Repeat ablative therapy in hereditary or multifocal renal cancer: Functional and oncological outcomes.
Fiche publication
Date publication
août 2020
Journal
Urologic oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GANGI Afshin, Pr LANG Hervé, Dr GARNON Julien, Dr TRICARD Thibault
Tous les auteurs :
Gaillard V, Tricard T, Garnon J, Cazzato RL, Dalili D, Gangi A, Lang H
Lien Pubmed
Résumé
To report managing renal tumors in patients at greater risk of repeated interventions (genetic predisposition, multifocal tumors) with thermoablative treatments (AT). A known significant challenge in these patients is the balance between nephron preservation and oncologic outcome.
Mots clés
Ablative therapies, Cryotherapy, Hereditary renal cancer
Référence
Urol. Oncol.. 2020 Aug 7;: